Global COVID-19 Diagnosis Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Latest Trends

Publisher : MRA | Format : PDF

Global COVID-19 Diagnosis Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

The COVID-19 pandemic has been declared as a global health crisis by WHO and is one of the greatest challenges ever faced by mankind since World War II. After its emergence in Wuhan, China by the end of December 2019, the virus has spread across 184 countries through the first quarter of 2020. Incidence of the infection is observed to be increasing daily in the Americas, Europe, and Africa. Although several strains of coronavirus have been identified and studied earlier, the new disease has been caused due to a novel strain and in no time turned into a pandemic due to a high R-naught. The virus is expected to impact the socioeconomic and political landscape of the countries, consequently leading to adverse economic impact.
Due to the COVID-19 pandemic, the global COVID-19 Diagnosis market size was US$ million in 2023 and is forecast to a readjusted size of US$ million by 2033 with a CAGR of % during the forecast period 2023-2033. Fully considering the economic change by this health crisis, RT-PCR accounting for % of the COVID-19 Diagnosis global market in 2023, is projected to value US$ million by 2033, growing at a revised % CAGR from 2023 to 2033. While Hospital segment is altered to an % CAGR throughout this forecast period.
The global key companies of COVID-19 Diagnosis include Cepheid, Abbott, Mesa Biotech, Microsens Dx, GenMark Diagnostics and Credo, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
The United States COVID-19 Diagnosis market size was US$ million in 2023, while China size was US$ million. The proportion of the United States was % in 2023, while China percentage was %, and it is predicted that China share will reach % in 2033, trailing a CAGR of % through the analysis period. As for the Europe COVID-19 Diagnosis landscape, Germany is projected to reach US$ million by 2033. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
The market research report offered here is a very useful resource that can help manufacturers, stakeholders, decision-makers, and other market participants to become familiar with every factor impacting the growth of the global COVID-19 Diagnosis market. The analysts authoring the report have closely studied key strategies adopted by top players of the global COVID-19 Diagnosis market. The report includes SWOT, and other market analyses to provide a clear and deep understanding of important aspects of the global COVID-19 Diagnosis market. Readers of the report can become informed about current and future trends of the global COVID-19 Diagnosis market and how they will impact market growth during the forecast period.

By Company

Cepheid
Abbott
Mesa Biotech
Microsens Dx
GenMark Diagnostics
Credo
Segment by Type
RT-PCR
Isothermal Nucleic Acid Amplification
Others

Segment by Application

Hospital
Laboratory
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Chapter Outline

Chapter 1Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on.
Chapter 2Revenue of COVID-19 Diagnosis in global and regional level.
Chapter 3Detailed analysis of COVID-19 Diagnosis companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 7Europe by type, by application and by country, revenue for each segment.
Chapter 8Asia Pacific by type, by application and by region, revenue for each segment.
Chapter 9Latin America by type, by application and by country, revenue for each segment.
Chapter 10Middle East and Africa, by type, by application and by country, revenue for each segment.
Chapter 11Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, COVID-19 Diagnosis revenue, gross margin, and recent development, etc.
Chapter 12Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 13Research Findings and Conclusion

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global COVID-19 Diagnosis Market Size Growth Rate by Type: 2018 VS 2023 VS 2033
1.2.2 RT-PCR
1.2.3 Isothermal Nucleic Acid Amplification
1.2.4 Others
1.3 Market by Application
1.3.1 Global COVID-19 Diagnosis Market Growth Rate by Application: 2018 VS 2023 VS 2033
1.3.2 Hospital
1.3.3 Laboratory
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Market Perspective
2.1 Global COVID-19 Diagnosis Market Size (2018-2033)
2.2 COVID-19 Diagnosis Market Size across Key Geographies Worldwide: 2018 VS 2023 VS 2033
2.3 Global COVID-19 Diagnosis Market Size by Region (2018-2023)
2.4 Global COVID-19 Diagnosis Market Size Forecast by Region (2024-2033)
2.5 Global Top 10 COVID-19 Diagnosis Countries Ranking by Market Size
3 COVID-19 Diagnosis Competitive by Company
3.1 Global COVID-19 Diagnosis Revenue by Players
3.1.1 Global COVID-19 Diagnosis Revenue by Players (2018-2023)
3.1.2 Global COVID-19 Diagnosis Market Share by Players (2018-2023)
3.2 Global COVID-19 Diagnosis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Covered: Ranking by COVID-19 Diagnosis Revenue
3.4 Global COVID-19 Diagnosis Market Concentration Ratio
3.4.1 Global COVID-19 Diagnosis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by COVID-19 Diagnosis Revenue in 2023
3.5 Global Key Players of COVID-19 Diagnosis Head office and Area Served
3.6 Global Key Players of COVID-19 Diagnosis, Product and Application
3.7 Global Key Players of COVID-19 Diagnosis, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Global COVID-19 Diagnosis Breakdown Data by Type
4.1 Global COVID-19 Diagnosis Historic Revenue by Type (2018-2023)
4.2 Global COVID-19 Diagnosis Forecasted Revenue by Type (2024-2033)
5 Global COVID-19 Diagnosis Breakdown Data by Application
5.1 Global COVID-19 Diagnosis Historic Market Size by Application (2018-2023)
5.2 Global COVID-19 Diagnosis Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America COVID-19 Diagnosis Revenue by Company (2021-2023)
6.2 North America COVID-19 Diagnosis Revenue by Type (2018-2033)
6.3 North America COVID-19 Diagnosis Revenue by Application (2018-2033)
6.4 North America COVID-19 Diagnosis Revenue by Country (2018-2033)
6.4.1 U.S.
6.4.2 Canada
7 Europe
7.1 Europe COVID-19 Diagnosis Revenue by Company (2021-2023)
7.2 Europe COVID-19 Diagnosis Revenue by Type (2018-2033)
7.3 Europe COVID-19 Diagnosis Revenue by Application (2018-2033)
7.4 Europe COVID-19 Diagnosis Revenue by Country (2018-2033)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
8 Asia Pacific
8.1 Asia Pacific COVID-19 Diagnosis Revenue by Company (2021-2023)
8.2 Asia Pacific COVID-19 Diagnosis Revenue by Type (2018-2033)
8.3 Asia Pacific COVID-19 Diagnosis Revenue by Application (2018-2033)
8.4 Asia Pacific COVID-19 Diagnosis Revenue by Region (2018-2033)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 India
8.4.5 Australia
8.4.6 Taiwan
8.4.7 Indonesia
8.4.8 Thailand
8.4.9 Malaysia
8.4.10 Philippines
8.4.11 Vietnam
9 Latin America
9.1 Latin America COVID-19 Diagnosis Revenue by Company (2021-2023)
9.2 Latin America COVID-19 Diagnosis Revenue by Type (2018-2033)
9.3 Latin America COVID-19 Diagnosis Revenue by Application (2018-2033)
9.4 Latin America COVID-19 Diagnosis Revenue by Country (2018-2033)
9.4.1 Mexico
9.4.2 Brazil
9.4.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa COVID-19 Diagnosis Revenue by Company (2021-2023)
10.2 Middle East and Africa COVID-19 Diagnosis Revenue by Type (2018-2033)
10.3 Middle East and Africa COVID-19 Diagnosis Revenue by Application (2018-2033)
10.4 Middle East and Africa COVID-19 Diagnosis Revenue by Country (2018-2033)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
11 Company Profiles
11.1 Cepheid
11.1.1 Cepheid Company Details
11.1.2 Cepheid Business Overview
11.1.3 Cepheid COVID-19 Diagnosis Products and Services
11.1.4 Cepheid COVID-19 Diagnosis Revenue in COVID-19 Diagnosis Business (2018-2023)
11.1.5 Cepheid COVID-19 Diagnosis SWOT Analysis
11.1.6 Cepheid Recent Development
11.2 Abbott
11.2.1 Abbott Company Details
11.2.2 Abbott Business Overview
11.2.3 Abbott COVID-19 Diagnosis Products and Services
11.2.4 Abbott COVID-19 Diagnosis Revenue in COVID-19 Diagnosis Business (2018-2023)
11.2.5 Abbott COVID-19 Diagnosis SWOT Analysis
11.2.6 Abbott Recent Development
11.3 Mesa Biotech
11.3.1 Mesa Biotech Company Details
11.3.2 Mesa Biotech Business Overview
11.3.3 Mesa Biotech COVID-19 Diagnosis Products and Services
11.3.4 Mesa Biotech COVID-19 Diagnosis Revenue in COVID-19 Diagnosis Business (2018-2023)
11.3.5 Mesa Biotech COVID-19 Diagnosis SWOT Analysis
11.3.6 Mesa Biotech Recent Development
11.4 Microsens Dx
11.4.1 Microsens Dx Company Details
11.4.2 Microsens Dx Business Overview
11.4.3 Microsens Dx COVID-19 Diagnosis Products and Services
11.4.4 Microsens Dx COVID-19 Diagnosis Revenue in COVID-19 Diagnosis Business (2018-2023)
11.4.5 Microsens Dx COVID-19 Diagnosis SWOT Analysis
11.4.6 Microsens Dx Recent Development
11.5 GenMark Diagnostics
11.5.1 GenMark Diagnostics Company Details
11.5.2 GenMark Diagnostics Business Overview
11.5.3 GenMark Diagnostics COVID-19 Diagnosis Products and Services
11.5.4 GenMark Diagnostics COVID-19 Diagnosis Revenue in COVID-19 Diagnosis Business (2018-2023)
11.5.5 GenMark Diagnostics COVID-19 Diagnosis SWOT Analysis
11.5.6 GenMark Diagnostics Recent Development
11.6 Credo
11.6.1 Credo Company Details
11.6.2 Credo Business Overview
11.6.3 Credo COVID-19 Diagnosis Products and Services
11.6.4 Credo COVID-19 Diagnosis Revenue in COVID-19 Diagnosis Business (2018-2023)
11.6.5 Credo COVID-19 Diagnosis SWOT Analysis
11.6.6 Credo Recent Development
12 COVID-19 Diagnosis Market Dynamics
12.1 COVID-19 Diagnosis Industry Trends
12.2 COVID-19 Diagnosis Market Drivers
12.3 COVID-19 Diagnosis Market Challenges
12.4 COVID-19 Diagnosis Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details

List of Figure

List of Tables
Table 1. Global COVID-19 Diagnosis Market Size Growth Rate (CAGR) by Type (US$ Million), 2018 VS 2023 VS 2033
Table 2. Key Players of RT-PCR
Table 3. Key Players of Isothermal Nucleic Acid Amplification
Table 4. Key Players of Others
Table 5. Global COVID-19 Diagnosis Market Size Growth Rate by Application (US$ Million), 2018 VS 2023 VS 2033
Table 6. Global COVID-19 Diagnosis Market Size (US$ Million) Growth Rate (CAGR) by Region: 2018 VS 2023 VS 2033
Table 7. Global COVID-19 Diagnosis Revenue by Region (2018-2023) & (US$ Million)
Table 8. Global COVID-19 Diagnosis Revenue Forecast by Region (2024-2033) & (US$ Million)
Table 9. Global COVID-19 Diagnosis Market Size of Top 10 Countries, 2018 VS 2023 VS 2033, (US$ Million)
Table 10. Global COVID-19 Diagnosis Revenue by Players (2018-2023) & (US$ Million)
Table 11. Global COVID-19 Diagnosis Market Share by Players (2018-2023)
Table 12. Global Top COVID-19 Diagnosis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in COVID-19 Diagnosis as of 2023)
Table 13. Ranking of Global Top COVID-19 Diagnosis Companies by Revenue (US$ Million) in 2023
Table 14. Global 5 Largest Players Market Share by COVID-19 Diagnosis Revenue (CR5 and HHI) & (2018-2023)
Table 15. Global Key Players of COVID-19 Diagnosis, Headquarters and Area Served
Table 16. Global Key Players of COVID-19 Diagnosis, Product and Application
Table 17. Global Key Players of COVID-19 Diagnosis, Date of Enter into This Industry
Table 18. Mergers & Acquisitions, Expansion Plans
Table 19. Global COVID-19 Diagnosis Market Size by Type (2018-2023) & (US$ Million)
Table 20. Global COVID-19 Diagnosis Revenue Market Share by Type (2018-2023)
Table 21. Global COVID-19 Diagnosis Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 22. Global COVID-19 Diagnosis Revenue Market Share by Type (2024-2033)
Table 23. Global COVID-19 Diagnosis Market Size by Application (2018-2023) & (US$ Million)
Table 24. Global COVID-19 Diagnosis Revenue Market Share by Application (2018-2023)
Table 25. Global COVID-19 Diagnosis Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 26. Global COVID-19 Diagnosis Revenue Market Share by Application (2024-2033)
Table 27. North America COVID-19 Diagnosis Revenue by Company (2021-2023) & (US$ Million)
Table 28. North America COVID-19 Diagnosis Revenue by Type (2018-2023) & (US$ Million)
Table 29. North America COVID-19 Diagnosis Revenue by Type (2024-2033) & (US$ Million)
Table 30. North America COVID-19 Diagnosis Revenue by Application (2018-2023) & (US$ Million)
Table 31. North America COVID-19 Diagnosis Revenue by Application (2024-2033) & (US$ Million)
Table 32. North America COVID-19 Diagnosis Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2023 VS 2033
Table 33. North America COVID-19 Diagnosis Revenue by Country (2018-2023) & (US$ Million)
Table 34. North America COVID-19 Diagnosis Revenue by Country (2024-2033) & (US$ Million)
Table 35. Europe COVID-19 Diagnosis Revenue by Company (2021-2023) & (US$ Million)
Table 36. Europe COVID-19 Diagnosis Revenue by Type (2018-2023) & (US$ Million)
Table 37. Europe COVID-19 Diagnosis Revenue by Type (2024-2033) & (US$ Million)
Table 38. Europe COVID-19 Diagnosis Revenue by Application (2018-2023) & (US$ Million)
Table 39. Europe COVID-19 Diagnosis Revenue by Application (2024-2033) & (US$ Million)
Table 40. Europe COVID-19 Diagnosis Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2023 VS 2033
Table 41. Europe COVID-19 Diagnosis Revenue by Country (2018-2023) & (US$ Million)
Table 42. Europe COVID-19 Diagnosis Revenue by Country (2024-2033) & (US$ Million)
Table 43. Asia Pacific COVID-19 Diagnosis Revenue by Company (2021-2023) & (US$ Million)
Table 44. Asia Pacific COVID-19 Diagnosis Revenue by Type (2018-2023) & (US$ Million)
Table 45. Asia Pacific COVID-19 Diagnosis Revenue by Type (2024-2033) & (US$ Million)
Table 46. Asia Pacific COVID-19 Diagnosis Revenue by Application (2018-2023) & (US$ Million)
Table 47. Asia Pacific COVID-19 Diagnosis Revenue by Application (2024-2033) & (US$ Million)
Table 48. Asia-Pacific COVID-19 Diagnosis Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2023 VS 2033
Table 49. Asia Pacific COVID-19 Diagnosis Revenue by Region (2018-2023) & (US$ Million)
Table 50. Asia Pacific COVID-19 Diagnosis Revenue by Region (2024-2033) & (US$ Million)
Table 51. Latin America COVID-19 Diagnosis Revenue by Company (2021-2023) & (US$ Million)
Table 52. Latin America COVID-19 Diagnosis Revenue by Type (2018-2023) & (US$ Million)
Table 53. Latin America COVID-19 Diagnosis Revenue by Type (2024-2033) & (US$ Million)
Table 54. Latin America COVID-19 Diagnosis Revenue by Application (2018-2023) & (US$ Million)
Table 55. Latin America COVID-19 Diagnosis Revenue by Application (2024-2033) & (US$ Million)
Table 56. Latin America COVID-19 Diagnosis Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2023 VS 2033
Table 57. Latin America COVID-19 Diagnosis Revenue by Country (2018-2023) & (US$ Million)
Table 58. Latin America COVID-19 Diagnosis Revenue by Country (2024-2033) & (US$ Million)
Table 59. Middle East and Africa COVID-19 Diagnosis Revenue by Company (2021-2023) & (US$ Million)
Table 60. Middle East and Africa COVID-19 Diagnosis Revenue by Type (2018-2023) & (US$ Million)
Table 61. Middle East and Africa COVID-19 Diagnosis Revenue by Type (2024-2033) & (US$ Million)
Table 62. Middle East and Africa COVID-19 Diagnosis Revenue by Application (2018-2023) & (US$ Million)
Table 63. Middle East and Africa COVID-19 Diagnosis Revenue by Application (2024-2033) & (US$ Million)
Table 64. Middle East and Africa COVID-19 Diagnosis Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2023 VS 2033
Table 65. Middle East and Africa COVID-19 Diagnosis Revenue by Country (2018-2023) & (US$ Million)
Table 66. Middle East and Africa COVID-19 Diagnosis Revenue by Country (2024-2033) & (US$ Million)
Table 67. Cepheid Company Details
Table 68. Cepheid Business Overview
Table 69. Cepheid COVID-19 Diagnosis Product and Services
Table 70. Cepheid COVID-19 Diagnosis Revenue in COVID-19 Diagnosis Business (2018-2023) & (US$ Million)
Table 71. Cepheid COVID-19 Diagnosis SWOT Analysis
Table 72. Cepheid Recent Development
Table 73. Abbott Company Details
Table 74. Abbott Business Overview
Table 75. Abbott COVID-19 Diagnosis Product and Services
Table 76. Abbott COVID-19 Diagnosis Revenue in COVID-19 Diagnosis Business (2018-2023) & (US$ Million)
Table 77. Abbott COVID-19 Diagnosis SWOT Analysis
Table 78. Abbott Recent Development
Table 79. Mesa Biotech Company Details
Table 80. Mesa Biotech Business Overview
Table 81. Mesa Biotech COVID-19 Diagnosis Product and Services
Table 82. Mesa Biotech COVID-19 Diagnosis Revenue in COVID-19 Diagnosis Business (2018-2023) & (US$ Million)
Table 83. Mesa Biotech COVID-19 Diagnosis SWOT Analysis
Table 84. Mesa Biotech Recent Development
Table 85. Microsens Dx Company Details
Table 86. Microsens Dx Business Overview
Table 87. Microsens Dx COVID-19 Diagnosis Product and Services
Table 88. Microsens Dx COVID-19 Diagnosis Revenue in COVID-19 Diagnosis Business (2018-2023) & (US$ Million)
Table 89. Microsens Dx COVID-19 Diagnosis SWOT Analysis
Table 90. Microsens Dx Recent Development
Table 91. GenMark Diagnostics Company Details
Table 92. GenMark Diagnostics Business Overview
Table 93. GenMark Diagnostics COVID-19 Diagnosis Product and Services
Table 94. GenMark Diagnostics COVID-19 Diagnosis Revenue in COVID-19 Diagnosis Business (2018-2023) & (US$ Million)
Table 95. GenMark Diagnostics COVID-19 Diagnosis SWOT Analysis
Table 96. GenMark Diagnostics Recent Development
Table 97. Credo Company Details
Table 98. Credo Business Overview
Table 99. Credo COVID-19 Diagnosis Product and Services
Table 100. Credo COVID-19 Diagnosis Revenue in COVID-19 Diagnosis Business (2018-2023) & (US$ Million)
Table 101. Credo COVID-19 Diagnosis SWOT Analysis
Table 102. Credo Recent Development
Table 103. COVID-19 Diagnosis Market Trends
Table 104. COVID-19 Diagnosis Market Drivers
Table 105. COVID-19 Diagnosis Market Challenges
Table 106. COVID-19 Diagnosis Market Restraints
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
List of Figures
Figure 1. COVID-19 Diagnosis Product Picture
Figure 2. Global COVID-19 Diagnosis Market Size by Type (US$ Million): 2018 VS 2023 VS 2033
Figure 3. Global COVID-19 Diagnosis Market Share by Type: 2023 VS 2033
Figure 4. RT-PCR Features
Figure 5. Isothermal Nucleic Acid Amplification Features
Figure 6. Others Features
Figure 7. Global COVID-19 Diagnosis Market Size by Application (US$ Million): 2018 VS 2023 VS 2033
Figure 8. Global COVID-19 Diagnosis Market Share by Application: 2023 VS 2033
Figure 9. Hospital
Figure 10. Laboratory
Figure 11. COVID-19 Diagnosis Report Years Considered
Figure 12. Global COVID-19 Diagnosis Revenue, (US$ Million), 2018 VS 2023 VS 2033
Figure 13. Global COVID-19 Diagnosis Market Size 2018-2033 (US$ Million)
Figure 14. Global COVID-19 Diagnosis Market Size Market Share by Region: 2023 VS 2033
Figure 15. Global COVID-19 Diagnosis Revenue Market Share by Region in 2018 VS 2023
Figure 16. Global COVID-19 Diagnosis Revenue Market Share Forecast by Region (2024-2033)
Figure 17. Global Top 10 COVID-19 Diagnosis Countries Ranking by Market Size (US$ Million) in 2023
Figure 18. Global COVID-19 Diagnosis Market Size of Top 10 Countries, 2018 VS 2023 VS 2033, (US$ Million)
Figure 19. Global COVID-19 Diagnosis Market Share by Players in 2023
Figure 20. Global Top COVID-19 Diagnosis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in COVID-19 Diagnosis as of 2023)
Figure 21. The Top 10 and 5 Players Market Share by COVID-19 Diagnosis Revenue in 2023
Figure 22. North America COVID-19 Diagnosis Revenue Market Share by Company in 2023
Figure 23. North America COVID-19 Diagnosis Revenue Market Share by Type (2018-2033)
Figure 24. North America COVID-19 Diagnosis Revenue Market Share by Application (2018-2033)
Figure 25. North America COVID-19 Diagnosis Revenue Share by Country (2018-2033)
Figure 26. U.S. COVID-19 Diagnosis Revenue (2018-2033) & (US$ Million)
Figure 27. Canada COVID-19 Diagnosis Revenue (2018-2033) & (US$ Million)
Figure 28. Europe COVID-19 Diagnosis Revenue Market Share by Company in 2023
Figure 29. Europe COVID-19 Diagnosis Revenue Market Share by Type (2018-2033)
Figure 30. Europe COVID-19 Diagnosis Revenue Market Share by Application (2018-2033)
Figure 31. Europe COVID-19 Diagnosis Revenue Share by Country (2018-2033)
Figure 32. Germany COVID-19 Diagnosis Revenue (2018-2033) & (US$ Million)
Figure 33. France COVID-19 Diagnosis Revenue (2018-2033) & (US$ Million)
Figure 34. U.K. COVID-19 Diagnosis Revenue (2018-2033) & (US$ Million)
Figure 35. Italy COVID-19 Diagnosis Revenue (2018-2033) & (US$ Million)
Figure 36. Russia COVID-19 Diagnosis Revenue (2018-2033) & (US$ Million)
Figure 37. Asia Pacific COVID-19 Diagnosis Revenue Market Share by Company in 2023
Figure 38. Asia Pacific COVID-19 Diagnosis Revenue Market Share by Type (2018-2033)
Figure 39. Asia Pacific COVID-19 Diagnosis Revenue Market Share by Application (2018-2033)
Figure 40. Asia Pacific COVID-19 Diagnosis Revenue Share by Region (2018-2033)
Figure 41. China COVID-19 Diagnosis Revenue (2018-2033) & (US$ Million)
Figure 42. Japan COVID-19 Diagnosis Revenue (2018-2033) & (US$ Million)
Figure 43. South Korea COVID-19 Diagnosis Revenue (2018-2033) & (US$ Million)
Figure 44. India COVID-19 Diagnosis Revenue (2018-2033) & (US$ Million)
Figure 45. Australia COVID-19 Diagnosis Revenue (2018-2033) & (US$ Million)
Figure 46. Taiwan COVID-19 Diagnosis Revenue (2018-2033) & (US$ Million)
Figure 47. Indonesia COVID-19 Diagnosis Revenue (2018-2033) & (US$ Million)
Figure 48. Thailand COVID-19 Diagnosis Revenue (2018-2033) & (US$ Million)
Figure 49. Malaysia COVID-19 Diagnosis Revenue (2018-2033) & (US$ Million)
Figure 50. Philippines COVID-19 Diagnosis Revenue (2018-2033) & (US$ Million)
Figure 51. Vietnam COVID-19 Diagnosis Revenue (2018-2033) & (US$ Million)
Figure 52. Latin America COVID-19 Diagnosis Revenue Market Share by Company in 2023
Figure 53. Latin America COVID-19 Diagnosis Revenue Market Share by Type (2018-2033)
Figure 54. Latin America COVID-19 Diagnosis Revenue Market Share by Application (2018-2033)
Figure 55. Latin America COVID-19 Diagnosis Revenue Share by Country (2018-2033)
Figure 56. Mexico COVID-19 Diagnosis Revenue (2018-2033) & (US$ Million)
Figure 57. Brazil COVID-19 Diagnosis Revenue (2018-2033) & (US$ Million)
Figure 58. Argentina COVID-19 Diagnosis Revenue (2018-2033) & (US$ Million)
Figure 59. Middle East and Africa COVID-19 Diagnosis Revenue Market Share by Company in 2023
Figure 60. Middle East and Africa COVID-19 Diagnosis Revenue Market Share by Type (2018-2033)
Figure 61. Middle East and Africa COVID-19 Diagnosis Revenue Market Share by Application (2018-2033)
Figure 62. Middle East and Africa COVID-19 Diagnosis Revenue Share by Country (2018-2033)
Figure 63. Turkey COVID-19 Diagnosis Revenue (2018-2033) & (US$ Million)
Figure 64. Saudi Arabia COVID-19 Diagnosis Revenue (2018-2033) & (US$ Million)
Figure 65. UAE COVID-19 Diagnosis Revenue (2018-2033) & (US$ Million)
Figure 66. Cepheid Revenue Growth Rate in COVID-19 Diagnosis Business (2018-2023)
Figure 67. Abbott Revenue Growth Rate in COVID-19 Diagnosis Business (2018-2023)
Figure 68. Mesa Biotech Revenue Growth Rate in COVID-19 Diagnosis Business (2018-2023)
Figure 69. Microsens Dx Revenue Growth Rate in COVID-19 Diagnosis Business (2018-2023)
Figure 70. GenMark Diagnostics Revenue Growth Rate in COVID-19 Diagnosis Business (2018-2023)
Figure 71. Credo Revenue Growth Rate in COVID-19 Diagnosis Business (2018-2023)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed

Global COVID-19 Diagnosis Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

Global COVID-19 Diagnosis Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

By Company

Segment by Application

Chapter Outline

Table of Content

List of Figure

Select User License

$4200 Single Licence

$6000 Enterprise Licence

$9100 Corporate Licence

Note : All prices in USD

FAQ'S

User License?

Delivery Time?

How do I place an order?

What is the Payment Options?

Is there a discount for multiple purchases?

Mode of Report Delivery?

Top Industries